This may reflect distinct transcriptional programs for AR to both evade the effects of ADT and promote metastases, and sheds light on the dynamic interactions of AR to maintain signaling throughout the prostate cancer progression, despite changes in androgen availability. This evidence concerns the gene AR and Familial prostate cancer.